Johns Hopkins HIV Guide
Moxifloxacin
Moxifloxacin is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Acute exacerbations of chronic bronchitis (AECB)
- Acute bacterial sinusitis (ABS)
- Use for AECB and ABS indications should be avoided for routine use due recent FDA warning (Black Box warning) regarding serious and potentially permanent side effects (tendonitis and tendon rupture, peripheral neuropathy, and CNS side effects).
- FDA safety warning regarding fluoroquinolone use
- Community-acquired pneumonia
- Skin and skin structure infections (including complicated)
- Complicated intra-abdominal infections
- Bacterial conjunctivitis (ophthalmic drops)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of M. tuberculosis including MDR and XDR-TB (in combination with other agents)
- Treatment of MAI and other non-TB mycobacterial infections (in combination with other agents)
- Alternative therapy for treatment of S. pneumoniae and H. influenzae meningitis in patients who have severe penicillin allergies.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Acute exacerbations of chronic bronchitis (AECB)
- Acute bacterial sinusitis (ABS)
- Use for AECB and ABS indications should be avoided for routine use due recent FDA warning (Black Box warning) regarding serious and potentially permanent side effects (tendonitis and tendon rupture, peripheral neuropathy, and CNS side effects).
- FDA safety warning regarding fluoroquinolone use
- Community-acquired pneumonia
- Skin and skin structure infections (including complicated)
- Complicated intra-abdominal infections
- Bacterial conjunctivitis (ophthalmic drops)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of M. tuberculosis including MDR and XDR-TB (in combination with other agents)
- Treatment of MAI and other non-TB mycobacterial infections (in combination with other agents)
- Alternative therapy for treatment of S. pneumoniae and H. influenzae meningitis in patients who have severe penicillin allergies.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: April 4, 2017
Citation
Avdic, Edina, and Paul A Pham. "Moxifloxacin." Johns Hopkins HIV Guide, 2017. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545260/all/Moxifloxacin.
Avdic E, Pham PA. Moxifloxacin. Johns Hopkins HIV Guide. 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545260/all/Moxifloxacin. Accessed March 22, 2023.
Avdic, E., & Pham, P. A. (2017). Moxifloxacin. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545260/all/Moxifloxacin
Avdic E, Pham PA. Moxifloxacin [Internet]. In: Johns Hopkins HIV Guide. ; 2017. [cited 2023 March 22]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545260/all/Moxifloxacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Moxifloxacin
ID - 545260
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2017/04/04/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545260/all/Moxifloxacin
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
